Predicted protein targets (top 9)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | PIK3CA | P42336 | 16/20 | 0.50 |
| ▸ | PIK3CD | O00329 | 6/20 | 0.50 |
| ▸ | MTOR | P42345 | 4/20 | 0.50 |
| ▸ | PIK3CB | P42338 | 1/20 | 0.50 |
| ▸ | PIK3CG | P48736 | 1/20 | 0.50 |
| ▸ | ATR | Q13535 | 4/20 | 0.43 |
| ▸ | TAF1 | P21675 | 2/20 | 0.43 |
| ▸ | PRKDC | P78527 | 1/20 | 0.43 |
| ▸ | ATRIP | Q8WXE1 | 1/20 | 0.43 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL3926674 | 0.97 | PIK3CA (0.49) | PIK3CAPIK3CDMTORPIK3CBPIK3CG | |
| SCHEMBL3935751 | 0.95 | PIK3CA (0.51) | PIK3CAPIK3CDMTORPIK3CBPIK3CG | |
| SCHEMBL3938225 | 0.93 | PIK3CA (0.50) | PIK3CAPIK3CDMTORPIK3CBPIK3CG | |
| SCHEMBL3935688 | 0.93 | PIK3CA (0.51) | PIK3CAPIK3CDMTORPIK3CBPIK3CG | |
| SCHEMBL3927935 | 0.93 | PIK3CA (0.47) | PIK3CAPIK3CDMTORPIK3CBPIK3CG | |
| SCHEMBL3937959 | 0.93 | PIK3CA (0.53) | PIK3CAPIK3CDMTORPIK3CBPIK3CG | |
| SCHEMBL3928799 | 0.92 | PIK3CA (0.49) | PIK3CAPIK3CDMTORPIK3CBPIK3CG | |
| SCHEMBL3926537 | 0.92 | PIK3CA (0.49) | PIK3CAPIK3CDMTORPIK3CBPIK3CG | |
| SCHEMBL3932817 | 0.92 | PIK3CA (0.48) | PIK3CAPIK3CDMTORPIK3CBPIK3CG | |
| SCHEMBL3924613 | 0.91 | PIK3CA (0.48) | PIK3CAPIK3CDMTORPIK3CBPIK3CG |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-2074118-A2 | TRISUBSTITUTED PYRIMIDINE DERIVATIVES FOR THE TREATMENT OF PROLIFERATIVE DISEASES | AstraZeneca AB (SE) | 2009-07-01 | — | — | EP | disclosed |
| WO-2009007748-A2 | TRISUBSTITUTED PYRIMIDINE DERIVATIVES FOR THE TREATMENT OF PROLIFERATIVE DISEASES | ASTRAZENECA AB (SE) | 2009-01-15 | — | — | WO | disclosed |